During 2018 Q3 the big money sentiment is 0.75. That’s change of 2018Q2’s as. 2 investors sold all, 2 reduced holdings as DENTSPLY SIRONA Inc. ratio is flat. 2 increased stakes while only 1 funds acquired stakes. Funds hold 160,741 shares thus 55.84% less from 2018Q2’s 364,014 shares.
West Oak Cap Lc holds 0% of its capital in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) for 140 shs. Gemmer Asset Llc has 0% invested in DENTSPLY SIRONA Inc. (NASDAQ:XRAY). Cardinal Cap Management accumulated 0.75% or 69,937 shs. Tirschwell & Loewy reported 0.06% stake. Cibc Markets holds 0.02% or 66,847 shs in its capital. Kentucky Retirement Systems holds 11,778 shs or 0.04% of its capital.

DENTSPLY SIRONA Inc. registered $279,140 net activity with 0 buys and 1 sale since December 3, 2018.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Ratings Coverage

A total of 2 analysts rate Dentsply Sirona (NASDAQ:XRAY) as follows: 1 “Buy”, 1 “Hold” and 0 “Sell”. Тherefore 50% are bullish. (NASDAQ:XRAY) has 2 ratings reports on Feb 15, 2019 according to StockzIntelligence. On Friday, October 19 the company was upgraded by Goldman Sachs. Listed here are DENTSPLY SIRONA Inc. (NASDAQ:XRAY) PTs and latest ratings.

17/01/2019 Broker: UBS Rating: Neutral New Target: $42 Initiates Coverage On
19/10/2018 Broker: Goldman Sachs Old Rating: Sell New Rating: Buy New Target: $44 Upgrade

XRAY reached $43.69 during the last trading session after $0.01 change.DENTSPLY SIRONA Inc. has volume of 291,901 shares. Since February 15, 2018 XRAY has declined 43.90% and is downtrending. XRAY underperformed by 43.90% the S&P 500.

DENTSPLY SIRONA Inc. designs, develops, makes, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide.The firm is valued at $9.72 billion. It operates through two divisions, Dental and Healthcare Consumables; and Technologies.Currently it has negative earnings. The firm provides dental consumable products, including endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprising dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

For more DENTSPLY SIRONA Inc. (NASDAQ:XRAY) news published briefly go to: Nasdaq.com, Nasdaq.com, Nasdaq.com, Nasdaq.com or Nasdaq.com. The titles are as follows: “Here’s Why Investors Should Hold DENTSPLY (XRAY) Stock Now – Nasdaq” published on January 04, 2019, “Here’s Why You Should Dump DENTSPLY (XRAY) Stock Right Now – Nasdaq” on August 13, 2018, “Here’s Why You Should Sell DENTSPLY SIRONA (XRAY) Stock Now – Nasdaq” with a publish date: May 18, 2018, “Research Report Identifies Norfolk Southern, DENTSPLY SIRONA, Healthcare Realty Trust, PTC, Intellia Therapeutics, and El Paso Electric with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement – Nasdaq” and the last “What’s in Store for DENTSPLY (XRAY) This Earnings Season? – Nasdaq” with publication date: May 02, 2018.